Varda Space Industries’ Post

Space-Produced Pharmaceuticals: Varda’s Orbital Mission Returns to Earth HIGHLIGHTS Varda's space capsule successfully returns with drugs. NewSpace industry revolutionizes microgravity manufacturing. Space-produced pharmaceuticals show promising future. #Space #Varda #OrbitalMission #Earth Learn More: https://lnkd.in/d5HYSYw7

👓 Pharmaceutical discovery through a gravitational lens: Robbie Fernwell interviewed president and co-founder of Varda Space Industries , Delian Asparouhov, about the company's work in leveraging microgravity environments for pharmaceutical work. The micro-gravity environment of the cosmic domain opens up a new world of opportunities for formulating small molecules and biologics. With positive results in a resent mission, successfully crystallising the least stable metastable Form III of ritonavir in space, achieving a purity rate of 98.5%. Results were published in a research paper: https://lnkd.in/ec_ytY3n https://lnkd.in/eDA__Xui

Redwire Space Announces First Spaceflight Mission for New Cutting-Edge Pharmaceutical Drug Development Lab 🚀 💊 The PIL-BOX-01 mission, a revolutionary step towards advancing pharmaceutical drug development. Here's what you need to know: ▪️ Innovative Platform: PIL-BOX offers pharmaceutical companies a unique opportunity to grow small-batch crystals of protein-based pharmaceuticals in space. ▪️ Partnership with Eli Lilly: Redwire collaborates with Eli Lilly and Company to conduct experiments focused on developing treatments for diabetes, cardiovascular disease, and pain. ▪️ Microgravity Advantage: Growing crystals in space can yield more uniform products, enhancing drug discovery and development processes. ▪️ Bioprinting Breakthrough: Redwire's BioFabrication Facility (BFF) will bioprint cardiac tissue on orbit, paving the way for advanced medical solutions like heart patches. https://lnkd.in/e6UYNyEi #SpaceInnovation #PharmaceuticalResearch #BioTech #FutureMedicine #RedwireInSpace

Did you miss the PANIC Spring Webinar, "Oligonucleotide-based Therapeutics: NMR Techniques for Characterization"? Watch the recording here: https://lnkd.in/d86Nv5zr Celestine Chi (AstraZeneca), Robert Brinson (IBBR Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology (NIST)), Martial Piotto (#Bruker), and Igor Dikiy (Regeneron Pharmaceuticals) discuss the latest advancements in NMR oligonucleotide-based drug characterization. This webinar is a collaboration between PANIC NMR and Bruker. #PANICnmr #NMR #Pharma #PharmaIndustry #Pharmaceuticals

What does the Future of Drug Discovery Look like? Learn more about FluoSphera's in vitro drug discovery solutions that reduce costs and increase speed and effectiveness.

Are you attending the SSRL/LCLS Users’ Meeting this week at the SLAC National Accelerator Laboratory? Don’t miss this ⬇️ presentation by Dr. Lance Westerhoff to learn about QuantumBio Inc.’s innovative, game changing #drugdiscovery methods. #pharmaceuticals #crystallography #CryoEM #structuralbiology

INM-089 is a small molecule drug candidate in preclinical studies for the treatment of age-related #macular degeneration #AMD. In vitro and in vivo studies of INM-089 have demonstrated: -Neuroprotection of photoreceptors and improved photoreceptor function -Improved integrity of the retinal pigment epithelium (RPE) -Reduction of extracellular autofluorescent (AF) deposits, a hallmark of dry AMD -Preservation of retinal function in the back of the eye -Improved thickness of “outer nuclear layer” (ONL) of the retina where photoreceptors are located Learn more about InMed's INM-089 for dry AMD: https://ow.ly/GJ6s50SwfBJ $INM #eyedisease #pharma #research

Scientists are exploring multifunctional nanoparticles capable of simultaneously delivering drugs, imaging diseased tissues, and monitoring therapeutic responses. The history of nanomedicine showcases the remarkable progress made in merging nanotechnology with medicine. Such symbiosis continues today – as evidenced in the recent NanoMed Europe #NME 2023 conference - with exciting developments in this broad field being presented.  We are thrilled to share that Aimee Cawley’s latest piece, that reflects on the state of innovation in nanomedicine following the NanoMed Europe #NME 2023 conference, has gone live in European Pharmaceutical Manufacturer (EPM.) #intellectualproperty #IP #NanoMed #NanoMedEurope2023 #nanomedicine #medtech #medtechinnovation #liverpool #EPM #Europeanpharmaceuticalmanufacturer https://lnkd.in/eN4RHCQR

Did you miss the PANIC Spring Webinar, "Oligonucleotide-based Therapeutics: NMR Techniques for Characterization"? Watch the recording here: https://lnkd.in/dCN9yG-8 Celestine Chi (AstraZeneca), Robert Brinson (IBBR Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology (NIST)), Martial Piotto (#Bruker), and Igor Dikiy (Regeneron Pharmaceuticals) discuss oligonucleotides and NMR. This webinar is a collaboration between PANIC NMR and Bruker. #PANICnmr #NMR #Pharma #PharmaIndustry #Pharmaceuticals

I recently interviewed Delian Asparouhov, Co-Founder of Varda Space Industries. Varda blasts pharmaceutical compounds into space on SpaceX rockets, leveraging microgravity to enhance drug formulations for bioavailability, shelf-life and more. This is a big deal. In February, their W-1 capsule returned to Earth after successfully crystallising ritonavir, an antiviral drug used in the treatment of HIV and hepatitis C, achieving a 98.5% purity rate. According to Delian, "The space drugs cooked real good!" Support founders and companies with character. Read here! https://lnkd.in/gbugP49j #Pharmaceuticals #Microgravity #Biopharma #Innovation #VardaSpaceIndustries #SpaceTech #DrugDevelopment #PharmaceuticalTechnology #PharmaTechnologyFocus #GlobalData #Ritonavir #SpaceX